Adaptive Biotechnologies Insider Sells $8.5 Million in Stock After Strong One-Year Return

Harlan S. Robins, the chief scientific officer of Adaptive Biotechnologies (NASDAQ:ADPT), sold $8.5 million worth of shares on July 2, 2026, following an 85% one-year return for the stock. The sale was conducted under a Rule 10b5-1 trading plan and occurred at a price slightly above the recent market close.

By Jonathan Ponciano, The Motley Fool Mon, July 13, 2026 at 12:58 AM GMT+3 4 min read · Yahoo Finance · July 12, 2026, 21:58 UTC

Tickers: $ADPT

Topics: Rule 10b5-1 trading plan SEC filing stock sale

Read the full article at Yahoo Finance

More World news

Standard Nuclear Reports $577.2 Million Contract Backlog and Targets 2027 DOE Authorization Seeking Alpha · November 12, 2026, 18:10 UTC
Nuwellis Reports Q3 2026 Revenue of $2.2 Million and Improved Operating Loss Motley Fool · November 12, 2026, 18:09 UTC
Nebius Group Reports Strong Revenue Growth Amidst Capacity Delays and Increased Capital Expenditure Motley Fool · November 12, 2026, 18:11 UTC
Pelagos Insurance Reports Q3 2026 Earnings with Increased Gross Premiums Written Motley Fool · November 12, 2026, 18:11 UTC
Sprott Physical Gold Trust USD Reports Q3 Net Income of $508.82 Million Seeking Alpha · November 12, 2026, 18:07 UTC
NYSE Gains $500 Billion in Market Capitalization via Nine Major Listing Transfers PR Newswire · November 12, 2026, 18:05 UTC
PenFed Foundation Grants $25,000 to Northern Virginia Vietnam Veterans Foundation PR Newswire · November 12, 2026, 18:06 UTC
Allstate Announces Quarterly Dividend of $1.08 Per Share Seeking Alpha · November 12, 2026, 18:01 UTC
Pinnacle Bankshares Increases Quarterly Dividend to $0.35 Per Share Seeking Alpha · November 12, 2026, 18:02 UTC
Avidbank Reports Third Quarter 2026 Earnings Growth Driven by Core Deposits and C&I Lending Motley Fool · November 12, 2026, 18:00 UTC